Valuation: Boston Scientific Corporation

Market Cap 66.06B 59.07B 54.65B 49.48B 92.61B 6,285B 94.12B 658B 260B 3,287B 248B 243B 10,408B P/E 2026 *
17.3x
P/E 2027 * 18.1x
Enterprise Value 72.47B 64.8B 59.95B 54.28B 102B 6,894B 103B 721B 285B 3,606B 272B 266B 11,418B EV / Sales 2026 *
3.43x
EV / Sales 2027 * 3.23x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day-0.24%
1 week+1.18%
Current month+4.42%
1 month+3.78%
3 months+3.01%
6 months-26.57%
Current year-52.20%
1 week 43.92
Extreme 43.915
46.16
1 month 41.38
Extreme 41.385
46.16
Current year 41.38
Extreme 41.385
100.9
1 year 41.38
Extreme 41.385
105.65
3 years 41.38
Extreme 41.385
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
25/8/26 Buy

Director

2,040 0.0001%
11/8/26 Other

Controller/Auditor

2,930 0.0002%
10/8/26 Other

Chief Financial Officer

9,908 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%+1.18%-54.92%-8.44% 66.06B
+1.64%+0.81%+19.63%+55.60% 253B
+1.07%+3.81%+4.47%+20.29% 164B
-0.15%+4.26%-17.36%+74.03% 157B
-1.50%+0.44%+8.59%+67.34% 51.52B
+1.03%+3.07%-14.62%-8.28% 52.64B
+1.67%+3.83%+19.00%+44.25% 52.2B
+1.67%+3.57%+18.87%+68.69% 49.61B
+0.51%+5.00%+26.84%+86.53% 44.8B
+0.60%+3.19%+170.74%+142.80% 40.93B
Average +0.47%+2.92%+18.12%+54.28% 93.14B
Weighted average by Cap. +0.71%+2.67%+9.82%+50.36%

Financials

2026 *2027 *
Net sales 21.13B 18.89B 17.48B 15.82B 29.62B 2,010B 30.1B 210B 83.19B 1,051B 79.29B 77.6B 3,329B 22.14B 19.79B 18.31B 16.58B 31.03B 2,106B 31.54B 220B 87.17B 1,102B 83.08B 81.31B 3,488B
Net income 3.75B 3.36B 3.1B 2.81B 5.26B 357B 5.35B 37.36B 14.78B 187B 14.09B 13.78B 591B 3.68B 3.29B 3.04B 2.75B 5.15B 350B 5.24B 36.59B 14.47B 183B 13.8B 13.5B 579B
Net Debt 6.41B 5.73B 5.3B 4.8B 8.99B 610B 9.13B 63.82B 25.24B 319B 24.06B 23.54B 1,010B 5.49B 4.91B 4.55B 4.12B 7.7B 523B 7.83B 54.7B 21.64B 273B 20.62B 20.18B 866B
Projected Income Statement - Annual - Boston Scientific Corporation
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
26/10/26 USD 45.58 -0.24% 11,928,715
23/10/26 USD 45.69 -0.70% 8,772,772
22/10/26 USD 46.01 +3.37% 16,395,574
21/10/26 USD 44.51 -2.35% 15,193,231
20/10/26 USD 45.58 +1.18% 16,013,159
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Boston Scientific Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
45.58USD
Average target price
57.82USD
Spread / Average Target
+26.86%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Boston Scientific Corporation